Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Visual education tool to help postpartum first-time mothers recognize urgent warning signs

Official title: Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Run by Northwestern University · NCT06912776 · Data updated 2026-11-12

This project will test whether a simple picture-based education tool helps first-time English-speaking postpartum mothers recognize and report urgent maternal warning signs.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment40 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJune 20, 2025
Main results expectedMay 2027
Study endsJuly 2027
Registry record updatedJune 10, 2026
Trial IDNCT06912776 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are English-speaking, nulliparous women over 18 in the postpartum period who can provide informed consent.

Probably not a fit

Patients who are not fluent in English, have prior serious peripartum complications, require anticoagulation, have uncorrected visual or hearing impairments, or are healthcare providers may not receive benefit from these simplified visuals.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will develop and compare two visual aid images based on the Council on Patient Safety in Women's Health Care urgent maternal warning signs, focusing specifically on symptoms that occur after delivery. Eligible participants are English-speaking, nulliparous women over age 18 in the postpartum period who will view either visual aid (appendix A or B). The study will measure participants' understanding of the warning signs and their reported likelihood to seek care after viewing the images. The goal is to improve anatomical accuracy while keeping images simple enough for people with varying health literacy.

Why it matters

Potential benefit: If successful, the tool could help first-time postpartum mothers recognize dangerous symptoms sooner and seek care earlier.

How similar studies have gone: Prior visual education tools have improved symptom recognition in other clinical areas, though using an anatomically focused visual aid specifically for postpartum urgent maternal warning signs is a novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postpartum women
* Nulliparity
* Age \>18 years of age
* English speaking patients

Exclusion Criteria:

* Inability to provide informed written consent
* Refusal to participate in all study-related procedures
* Patients not fluent in English
* Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
* Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
* Patients with uncorrected visual or hearing impairment
* Healthcare providers (in which patients will have significant background knowledge)

Where it's running

  • Northwestern Medicine
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.